Progress is often evaluated using several markers, including: Weight and body composition trends Blood sugar markers such as fasting glucose or HbA1c Side-effect tolerance during dose increases Strength and muscle preservation during weight loss When these indicators are moving in the right direction, treatment is usually progressing appropriately
The GLP-1 drugs, with popular names like Wegovy and Ozempic, are glucagon-like peptide agonists that curb your appetite, helping patients in their quest to slim down
The cell volumization promotes an anabolic state that directly opposes the catabolic environment created by caloric restriction
Oncogene 24 , 47364740 (2005)
Katagiri, M., Satoh, A., Tsuji, S., & Shirasawa, T